Showing results (61-70 of 87) with videos related to
Sort By:
Pageof 9
Journal of Medicinal Chemistry|February 26, 2008
Searching for new NO-donor aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acidLoretta Lazzarato, Monica Donnola, Barbara Rolando, et al.Journal of Inflammation (London, England)|August 2, 2008
A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophagesCatriona M Turnbull, Paolo Marcarino, Tara A Sheldrake, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|May 11, 2019
Fluorescent Nitric Oxide Photodonors Based on BODIPY and Rhodamine AntennaeCristina Parisi, Mariacristina Failla, Aurore Fraix, et al.Bioorganic & Medicinal Chemistry|March 20, 2010
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs)Marco L Lolli, Barbara Rolando, Paolo Tosco, et al.IUBMB Life|April 12, 2026
Lipo-Glc-1,6-P2: A Bioprecursor Prodrug for Phosphomannomutase-2 Congenital Disorder of GlycosylationFederica Sodano, Maria Monticelli, Bruno Hay Mele, et al.Biomaterials Science|January 9, 2020
Enhancing doxorubicin anticancer activity with a novel polymeric platform photoreleasing nitric oxideFederica Sodano, Robert J Cavanagh, Amanda K Pearce, et al.Journal of Medicinal Chemistry|December 26, 2018
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem CellsChiara Riganti, Marialessandra Contino, Stefano Guglielmo, et al.Journal of Pineal Research|April 19, 2007
NO-donor melatonin derivatives: synthesis and in vitro pharmacological characterizationKonstantin Chegaev, Loretta Lazzarato, Barbara Rolando, et al.Pharmaceutics|May 27, 2023
Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to MelanomaFederica Foglietta, Annalisa Bozza, Chiara Ferraris, et al.Journal of Medicinal Chemistry|April 28, 2016
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug ResistanceKonstantin Chegaev, Barbara Rolando, Daniela Cortese, et al.Pageof 9